We are grateful for external funding from The Research Council of Norway, Norwegian Cancer Society, South-Eastern Norway Regional Health Authority and EU.
Tunheim G, Baranowska-Hustad M, Lund-Johansen F, Fossum E, Bhandari S, Kukule L, Møller TKR, Vikse EL, Bekkevold T, Oftung F, Robertson AH, Næss LM(2025) SARS-CoV-2 Infection With Alpha B.1.1.7 Virus Induced Higher Antibody Responses Than Earlier Non-VOC Variants During the First Waves of the COVID-19 Pandemic in Norway APMIS, 133(12), e70102 DOI 10.1111/apm.70102, PubMed 41376258
Fossum E, Vikse EL, Robertson AH, Wolf AS, Rohringer A, Trogstad L, Mjaaland S, Hungnes O, Bragstad K(2025) Low Levels of Neutralizing Antibodies Against SARS-CoV-2 KP.3.1.1 and XEC in Serum From Seniors in May 2024 Influenza Other Respir Viruses, 19(5), e70102 DOI 10.1111/irv.70102, PubMed 40369880
Gopalakrishnan RP, Østrøm MS, Skjeldal FM, Bakke O, Bogen B, Huszthy PC(2024) B Cells With Complementary B Cell Receptors Can Kill Each Other Eur J Immunol, 55(1), e202350890 DOI 10.1002/eji.202350890, PubMed 39520365
